1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with tretinoin in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (tretinoin) | Trials (tretinoin) | Recent Studies (post-2010) (tretinoin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 23,654 | 1,083 | 6,085 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | tretinoin (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.275 | |
| Retinoic acid receptor alpha | Homo sapiens (human) | 2.2542 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
| Retinoic acid receptor beta | Homo sapiens (human) | 0.7537 | |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.0057 | |
| Retinoic acid receptor gamma | Homo sapiens (human) | 0.0064 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | 0.004 | |
| Retinoic acid receptor beta | Mus musculus (house mouse) | 0.005 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.576 | |
| Nuclear receptor ROR-alpha | Homo sapiens (human) | 0.1995 | |
| Alpha-synuclein | Homo sapiens (human) | 3 | |
| Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | 0.5233 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.358 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.35 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.1995 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 0.82 | |
| 60 kDa chaperonin | Escherichia coli | 6.7 | |
| 10 kDa chaperonin | Escherichia coli | 6.7 | |
| Nuclear receptor ROR-beta | Homo sapiens (human) | 0.1259 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aepfelbacher, M; Lux, I; Weber, C; Weber, PC; Zimmer, B | 1 |
| Chambaut-Guerin, AM; Delbourg, I; Ribier, A; Thomopoulos, P; Ventura, MA | 1 |
| Bouma, BN; Chung-A-Hing, JE; Jansen, JW; van Giezen, JJ; Vegter, CB | 1 |
| Bonney, RJ; Chilton, FH; Darling, IM; Davern, LB; Franson, RC; Havens, MB; Nettleton, DO; Stanley, PL; Tramposch, KM | 1 |
| Bazan, NG; Fletcher, BS; Herschman, HR; Mukherjee, PK | 1 |
| Mutoh, H; Shimizu, T | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and tretinoin
| Article | Year |
|---|---|
Structure and regulation of platelet activating factor receptor gene.
Topics: Amino Acid Sequence; Animals; Base Sequence; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Endometrium; Endotoxins; Estrogens; Female; Gene Expression Regulation; Genes; Genes, Reporter; Humans; Macrophages; Mice; Molecular Sequence Data; Platelet Activating Factor; Platelet Membrane Glycoproteins; Promoter Regions, Genetic; Protein Conformation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Tretinoin; Triiodothyronine | 1997 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and tretinoin
| Article | Year |
|---|---|
Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increase in differentiated monocytic U937 cells.
Topics: Animals; Calcium; Cell Differentiation; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Masoprocol; Monocytes; Phospholipids; Platelet Activating Factor; Proadifen; SRS-A; Tretinoin | 1991 |
The adhesiveness of monocytic U937 cells is stimulated by pro-inflammatory agents and inhibited by adenosine 3':5'-cyclic monophosphate.
Topics: 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Alprostadil; Bucladesine; Calcitriol; Cell Adhesion; Cell Differentiation; Cell Line; Cyclic AMP; Diglycerides; Humans; Kinetics; Leukotriene B4; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Tretinoin | 1990 |
Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
Topics: Animals; Blood Cell Count; Blood Specimen Collection; Chemical Fractionation; Dexamethasone; Dogs; Fibrinolysis; Humans; Male; Mice; Pancreatic Elastase; Platelet Activating Factor; Rats; Rats, Wistar; Species Specificity; Tissue Plasminogen Activator; Tretinoin; Urokinase-Type Plasminogen Activator | 1994 |
Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
Topics: Administration, Topical; Anti-Inflammatory Agents; Arachidonic Acid; Dermatitis; Eicosanoids; Humans; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Tretinoin | 1994 |
Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene.
Topics: Animals; Cell Line; Drug Synergism; Gene Expression Regulation, Enzymologic; Mice; Platelet Activating Factor; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Rats; Sequence Deletion; Structure-Activity Relationship; Transcription, Genetic; Tretinoin | 1994 |